Upstream Bio (UPB) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 0.97.
- Upstream Bio's Equity Ratio rose 24047.6% to 0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97, marking a year-over-year increase of 24047.6%. This contributed to the annual value of 0.98 for FY2024, which is 19284.06% up from last year.
- As of Q3 2025, Upstream Bio's Equity Ratio stood at 0.97, which was up 24047.6% from 0.97 recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's Equity Ratio peaked at 0.98 during Q1 2025, and registered a low of 1.05 during Q4 2023.
- Over the past 3 years, Upstream Bio's median Equity Ratio value was 0.97 (recorded in 2025), while the average stood at 0.36.
- In the last 5 years, Upstream Bio's Equity Ratio surged by 19284.06% in 2024 and then soared by 24047.6% in 2025.
- Over the past 3 years, Upstream Bio's Equity Ratio (Quarter) stood at 1.05 in 2023, then surged by 192.84% to 0.98 in 2024, then decreased by 0.78% to 0.97 in 2025.
- Its Equity Ratio was 0.97 in Q3 2025, compared to 0.97 in Q2 2025 and 0.98 in Q1 2025.